The U.S. blockade of Iran’s shipping lanes in the Strait of Hormuz has fundamentally altered market dynamics, yet investors appear cautiously optimistic as earnings season unfolds. Despite President Trump’s aggressive move to choke off oil flows—a strategy designed to pressure Tehran—the immediate impact on global energy prices has been tempered, with Brent and West Texas Intermediate crude settling just under $100 per barrel. This moderation reflects both the complexity of disrupting a critical chokepoint and the resilience of alternative supply routes. While the blockade signals a significant geopolitical escalation, markets have not yet fully priced in the prolonged consequences, suggesting a degree of skepticism about sustained price spikes or broader economic fallout. The initial shock has given way to a more measured assessment, with traders weighing the likelihood of a negotiated settlement against the costs of extended confrontation.
Earnings reports from major financial institutions, including Goldman Sachs, have introduced further nuance to market sentiment. Goldman’s 19% jump in quarterly profit underscores the sector’s ability to capitalize on volatility, yet its stock declined due to concerns about how the Iran conflict might dampen initial public offerings and broader investment banking activity. This mixed performance highlights a central tension: while certain segments of the economy, particularly energy and defense, may benefit from heightened geopolitical tensions, others—such as consumer-facing industries—face headwinds from rising costs and uncertainty. The earnings calendar, featuring results from JPMorgan Chase, Citigroup, and others, will further illuminate which sectors are poised to lead or lag in the coming weeks, as corporate leaders grapple with the dual pressures of inflation, supply chain disruptions, and shifting global demand.
Beyond energy and finance, the ripple effects of the Iran conflict are evident in unexpected sectors. Luxury goods, for instance, have shown resilience, with LVMH reporting weak sales amid concerns over the war’s impact on tourism and discretionary spending. Conversely, airlines are confronting soaring fuel costs, with Delta and others raising fares by double-digit percentages to offset expenses, signaling a broader inflationary trend that could strain household budgets and dampen travel demand. Meanwhile, housing markets remain sluggish, as elevated mortgage rates—now hovering near 6.5%—continue to suppress home sales, even as prices climb to record levels. These divergent outcomes underscore the fragmented nature of the current economic landscape, where winners and losers emerge not just from geopolitical developments but from the interplay of monetary policy, corporate strategy, and consumer behavior. As markets navigate this complexity, the coming weeks will test the durability of optimism and the adaptability of businesses across industries.
Watch List
CREX
Creative Realities, Inc. (NASDAQ: CREX), a leader in digital signage, media, and AdTech solutions, announced its fiscal 2025 fourth-quarter results, marking a period of significant transformation following the acquisition of CDM. CEO Rick Mills highlighted that this strategic move positions the company for robust growth in fiscal 2026, with expectations of record-breaking performance driven by higher revenue growth and expanded margins. The integration of CDM is progressing smoothly, enabling Creative Realities to leverage economies of scale and offer enhanced value-added services across North America. For the quarter ending December 31, 2025, sales surged to $23.9 million from $11.0 million in the same period of fiscal 2024, with a substantial contribution of approximately $13.6 million attributed to CDM. Hardware revenue increased to $6.6 million from $3.9 million, while service revenue rose to $17.3 million from $7.2 million, reflecting both the impact of the acquisition and deployment timing. The company's consolidated gross profit reached $11.5 million compared to $4.9 million in the prior year, with a gross margin improvement to 47.9% from 44.2%. Operating expenses saw an increase due to the CDM acquisition, with sales and marketing expenses rising to $2.0 million and general and administrative expenses increasing to $8.9 million, including one-time costs related to the transaction. Despite these increases, Creative Real
ACI
Albertsons Companies, Inc. reported its fourth quarter and full-year results for fiscal 2025 on April 14, 2026, highlighting a year marked by disciplined execution despite challenges in pharmacy sales due to the Inflation Reduction Act. The company experienced a net loss of $481 million, or $0.94 per share, largely attributed to a $600 million charge related to an opioid settlement framework. However, adjusted figures showed a more positive picture with an adjusted net income of $252 million and adjusted EBITDA of $903 million for the fourth quarter. Throughout fiscal 2025, Albertsons saw identical sales increase by 2% and digital sales rise significantly by 21%, reflecting strong growth in its online presence. The company also expanded its loyalty program, adding 12% more members to reach over 51 million. Despite these gains, gross margin rates slightly decreased due to increased delivery and handling costs associated with the surge in digital sales. In terms of capital allocation, Albertsons announced a 13% increase in its common stock dividend and raised its share repurchase authorization to $2 billion. The company also completed significant debt refinancing efforts, issuing new notes to redeem existing ones. Looking ahead, Albertsons provided an outlook for fiscal 2026 with projected identical sales growth between 0% and 1%, adjusted EBITDA ranging from $3.85 billion to $3.925 billion, and capital expenditures estimated at $2 billion to $2.2 billion.
ING
ING has been actively progressing with its €1.1 billion share buyback program, initiated on October 30, 2025. During the week of April 7-10, 2026, ING repurchased 754,279 shares at an average price of €24.03, amounting to a total expenditure of €18,121,625.88. To date, the bank has acquired 44,386,020 shares under this program at an average cost of €23.41, with a cumulative investment of €1,039,203,251.22. This represents approximately 94.47% completion towards the maximum value of the buyback initiative. As part of its broader strategy to reduce share capital, ING continues to provide detailed updates on this program through its website. As a global financial institution with a strong European presence, ING Bank serves customers in over 100 countries, offering both retail and wholesale banking services through its workforce of more than 60,000 employees. The bank is committed to sustainability, which is central to its operations. This commitment has been recognized by independent research and ratings providers; notably, MSCI upgraded ING's ESG rating from 'AA' to 'AAA' in October 2025. Additionally, Sustainalytics rated ING’s management of ESG material risks as ‘Strong’ with a low-risk score of 18.0 as of June 2025. Consequently, ING Group shares are included in
KMX
On April 14, 2026, CarMax, Inc. reported its fiscal year-end results for February 28, 2026, announcing Keith Barr as the new President and CEO effective March 16, 2026. The company saw a modest increase in combined retail and wholesale unit sales to 303,969, up by 0.7% from the previous year. However, retail used vehicle sales experienced a decline of 0.8%, with comparable store sales dropping by 1.9%. This was reflected in a decrease in gross profit per retail used unit to $2,115, down by $207 due to strategic pricing adjustments aimed at improving sales trends. Wholesale units rose by 3.0%, but the average gross profit per wholesale unit fell by $105 to $940. The Extended Protection Plans (EPP) margin remained stable compared to last year. CarMax purchased a total of 270,000 vehicles from consumers and dealers, marking a slight increase of 0.4% over the previous year. Selling, general, and administrative expenses were consistent with the prior year at $611.3 million, despite restructuring charges and increased advertising costs being offset by reduced compensation and benefits. Excluding these charges, adjusted SG&A expenses decreased by $33.1 million or 5.4%. CarMax has also raised its target for SG&A reductions to $200 million in exit rate savings by the end of fiscal year 2027. CarMax
LEGN
On April 14, 2026, Legend Biotech Corporation, a foreign private issuer based in Somerset, New Jersey, filed a Form 6-K with the SEC, reporting preliminary sales figures for their product CARVYKTI. Under the collaboration and license agreement established on December 21, 2017, between Legend Biotech USA Inc., Legend Biotech Ireland Limited, Janssen Biotech, Inc., and Janssen Pharmaceutica N.V., the company announced approximately $597 million in net trade sales for the quarter ending March 31, 2026. These figures were provided by Janssen and have not been independently verified by Legend Biotech. The determination of revenue or gross profit related to these sales is pending completion of financial statements as of the period ended March 31, 2026. The report includes cautionary notes regarding forward-looking statements, highlighting that future expectations, plans, and prospects are subject to various risks and uncertainties. These include challenges in pharmaceutical development, unexpected clinical trial results, regulatory actions or delays, third-party partner activities, pricing pressures, and other factors discussed in Legend Biotech's March 10, 2026, Commission filing. The company emphasizes that actual outcomes may differ significantly from those anticipated due to these potential risks. Legend Biotech disclaims any obligation to update forward-looking statements based on new information or future events. This Form 6-K is incorporated by reference into the registration statements of Legend Biotech on Forms F-3
DEVS
On April 13, 2026, Alberta corporation, an emerging growth company, announced a significant business combination through a definitive Business Combination Agreement (BCA) with XCF Global, Inc., and Southern Energy Renewables Inc. This agreement follows the execution of a term sheet in January 2026, outlining the principal terms for this proposed merger. The transaction involves the formation of new subsidiaries under XCF—DevvStream Merger Sub Inc. and Southern Merger Sub Inc.—and is subject to customary closing conditions, including obtaining fairness opinions from both XCF and the Company. The structure of the transactions includes converting outstanding equity awards such as warrants, options, RSUs, and convertible notes into equivalent rights exercisable for or convertible into XCF Common Shares, adjusted based on a specified consideration per share. The process will involve special shareholder meetings to approve these transactions. Key conditions for closing include obtaining necessary regulatory approvals, ensuring no material adverse effects occur, and meeting financial benchmarks such as Southern's bond issuance and revenue targets for XCF. Termination fees are stipulated if the agreement is breached or alternative proposals are pursued within a year of termination. Support & Lock-Up Agreements have been signed by core securityholders to ensure voting in favor of the transactions, with certain transfer restrictions applied. Additionally, there is an option to spin-out or sell a newly formed holding company post-transaction, provided it does not adversely affect XCF or Southern. The Company has issued a press release regarding this agreement and
AVNS
On April 13, 2026, Avanos Medical, Inc., a medical device company, entered into a definitive merger agreement with A-AV Holdco I, Inc. and its subsidiary, A-AV MergerSub, Inc. This strategic move involves merging Merger Subsidiary into Avanos Medical, resulting in the latter becoming a wholly-owned subsidiary of A-AV Holdco I. The transaction is structured to ensure that all outstanding equity awards held by employees, including time-based restricted stock units (TRSUs) and performance-based restricted stock units (PRSUs), as well as options, are settled in cash at or shortly after the merger's effective time. The settlement for TRSU holders will be calculated based on the merger consideration per share of Avanos Medical stock multiplied by the number of shares they would have received if their awards were fully vested. PRSU holders' settlements will consider actual performance metrics up to the effective date, with adjustments for ongoing and future periods. Options that are in-the-money at the time of the merger will be exercised based on the difference between the merger consideration per share and the option's exercise price. The merger is subject to several closing conditions, including approval by a majority of Avanos Medical’s shareholders, compliance with antitrust regulations, and no prohibitive legal injunctions. The agreement also includes customary representations and covenants, such as maintaining business operations until closure or termination of the deal, and restrictions on soliciting alternative acquisition proposals. The
RIG
Transocean Ltd., a prominent player in the offshore drilling industry, has announced a significant development that underscores its ongoing partnership with Petrobras. On April 14, 2026, Transocean disclosed that it had secured a substantial contract extension valued at approximately $445 million. This extension, spanning 1,156 days, is set to continue directly from its current operations and will extend the rig's commitment through November 2030. The agreement marks an important milestone for Transocean, reinforcing its strategic collaboration with Petrobras and contributing significantly to its backlog. Prior to this extension period, which begins on April 1, 2026, and runs until September 2027—a duration of about 525 days—the existing backlog will see a reduction by approximately $20 million. This adjustment reflects the transition phase leading up to the commencement of the new contract. The announcement highlights Transocean's ability to maintain and expand its operational footprint in key markets, bolstering its financial position with this incremental backlog. A detailed press release accompanying this filing provides further insights into the specifics of the agreement and is incorporated by reference as part of Item 9.01 Financial Statements and Exhibits. This development not only strengthens Transocean's market presence but also demonstrates its resilience and adaptability in navigating the dynamic offshore drilling landscape.
LCID
On April 14, 2026, Lucid Group, Inc., a leading electric vehicle manufacturer, announced significant financial developments through private placements. The Public Investment Fund (PIF), via its majority stockholder Ayar Third Investment Company, agreed to purchase $550 million worth of Lucid’s Series C Convertible Preferred Stock in a private placement. Concurrently, SMB Holding Corporation, affiliated with Uber Technologies, Inc., committed to acquiring $200 million of Lucid's Class A common stock through another private placement. These transactions are expected to close shortly after the agreements were signed and aim to deepen the strategic partnership between Lucid and Uber. The Convertible Preferred Stock, which is senior to Common Stock in terms of dividends and liquidation distributions, carries a 9% annual compounded dividend rate starting June 30, 2026. It can be converted into approximately 50.85 million shares of Common Stock under certain conditions. Additionally, Lucid entered into a Second Vehicle Production Agreement with Uber, committing to supply at least 25,000 modified Midsize vehicles for use as robotaxis over six years. Lucid also amended its credit facilities, increasing the aggregate undrawn delayed draw term commitments by $500 million, bringing the total to approximately $2.5 billion under the DDTL Facility. This financial maneuvering is part of Lucid's broader strategy to enhance liquidity and support its ambitious production goals, including the anticipated start of Midsize Plus vehicle production in late 2028. These
CCLD
On April 13, 2026, CareCloud, Inc., a healthcare technology company, announced significant financial developments through its Form 8-K filing. The company entered into a Credit Agreement with Citizens Bank, N.A., Provident Bank, and other parties, establishing a $40 million term loan facility and a $10 million revolving credit facility. These facilities are set to mature on the fourth anniversary of their closing date, with the term loan amortizing in equal monthly principal installments beginning June 1, 2026. The interest rates for these borrowings will be based on Term SOFR, Daily Simple SOFR, or an alternate base rate, plus applicable margins. The Credit Facility includes standard affirmative and negative covenants, financial covenants, and events of default. Guarantees from certain subsidiaries and collateral pledges by Mahmud Haq, the Executive Chairman, secure these obligations. In return for pledging his accounts as additional collateral, Mr. Haq received a warrant to purchase 4,300,000 shares at $5 per share, with anti-dilution provisions and a net share settlement feature. Additionally, CareCloud entered into an At The Market (ATM) Offering Agreement with Citizens JMP on the same day, allowing for up to $60 million in stock sales over time. This agreement aims to capitalize on existing market conditions for the company's common stock, with proceeds intended for general corporate purposes such as potential acquisitions and working capital needs. Citizens will earn a
Economic Calendar
| Date | Event | Previous | Impact |
|---|---|---|---|
| 2026-04-14 06:00:00 | NFIB Business Optimism Index (Mar) | 98.800 | ⭐️ |
| 2026-04-14 06:00:00 | IMF Meeting | NaN | ⭐️ |
| 2026-04-14 08:30:00 | Core PPI YoY (Mar) | 3.900 | ⭐️ |
| 2026-04-14 08:30:00 | Producer Price Index MoM (Mar) | 0.700 | ⭐️⭐️⭐️ |
| 2026-04-14 08:30:00 | Producer Price Index (Mar) | 153.231 | ⭐️ |
| 2026-04-14 08:30:00 | PPI Ex Food, Energy and Trade YoY (Mar) | 3.500 | ⭐️ |
| 2026-04-14 08:30:00 | Producer Price Index YoY (Mar) | 3.400 | ⭐️ |
| 2026-04-14 08:30:00 | Core PPI MoM (Mar) | 0.500 | ⭐️⭐️ |
| 2026-04-14 08:30:00 | PPI Ex Food, Energy and Trade MoM (Mar) | 0.500 | ⭐️ |
| 2026-04-14 08:55:00 | Redbook YoY (Apr/11) | 7.600 | ⭐️ |
| 2026-04-14 11:30:00 | 52-Week Bill Auction | 3.485 | ⭐️ |
| 2026-04-14 12:15:00 | Fed Goolsbee Speech | NaN | ⭐️⭐️ |
| 2026-04-14 12:45:00 | Fed Barr Speech | NaN | ⭐️⭐️ |
| 2026-04-14 13:00:00 | Fed Collins Speech | NaN | ⭐️⭐️ |
| 2026-04-14 13:00:00 | Fed Barkin Speech | NaN | ⭐️ |
| 2026-04-14 16:30:00 | API Crude Oil Stock Change (Apr/10) | 3.719 | ⭐️⭐️ |